Using a Matrigel scaffold, IL-6-dependent DS-1 cells served as the tumor xenograft model, and human mesenchymal stem cells (hMSCs) served as a stromal IL-6 feeding-layer, based on their secretory profile [34–36]. This evidence concerns the gene IL6 and neoplasm.